- Home
- BTE vs ATRC Comparison
BTE vs ATRC Comparison
Compare BTE & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTE
- ATRC
- Stock Information
- Founded
- BTE 1993
- ATRC 2000
- Country
- BTE Canada
- ATRC United States
- Employees
- BTE N/A
- ATRC N/A
- Industry
- BTE Meat/Poultry/Fish
- ATRC Medical/Dental Instruments
- Sector
- BTE Consumer Staples
- ATRC Health Care
- Exchange
- BTE Nasdaq
- ATRC Nasdaq
- Market Cap
- BTE 1.8B
- ATRC 1.7B
- IPO Year
- BTE N/A
- ATRC 2005
- Fundamental
- Price
- BTE $2.29
- ATRC $36.56
- Analyst Decision
- BTE Hold
- ATRC Strong Buy
- Analyst Count
- BTE 1
- ATRC 10
- Target Price
- BTE $5.50
- ATRC $49.60
- AVG Volume (30 Days)
- BTE 24.0M
- ATRC 357.5K
- Earning Date
- BTE 10-30-2025
- ATRC 10-29-2025
- Dividend Yield
- BTE 2.77%
- ATRC N/A
- EPS Growth
- BTE N/A
- ATRC N/A
- EPS
- BTE 0.34
- ATRC N/A
- Revenue
- BTE $2,318,087,632.00
- ATRC $499,946,000.00
- Revenue This Year
- BTE N/A
- ATRC $16.32
- Revenue Next Year
- BTE N/A
- ATRC $12.37
- P/E Ratio
- BTE $6.63
- ATRC N/A
- Revenue Growth
- BTE N/A
- ATRC 16.28
- 52 Week Low
- BTE $1.36
- ATRC $27.71
- 52 Week High
- BTE $3.18
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- BTE 46.48
- ATRC 52.08
- Support Level
- BTE $2.18
- ATRC $35.93
- Resistance Level
- BTE $2.44
- ATRC $38.42
- Average True Range (ATR)
- BTE 0.10
- ATRC 1.23
- MACD
- BTE -0.01
- ATRC 0.04
- Stochastic Oscillator
- BTE 19.46
- ATRC 50.73
About BTE Baytex Energy Corp
Baytex Energy Corp is an oil and gas company. Geographically, the group operates in Canada and the United States. The company derives a majority of revenue from Canada. Its Canada segment includes the exploration, development, and production of crude oil and natural gas in Western Canada.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.